dapsone has been researched along with Pyoderma Gangrenosum in 41 studies
Pyoderma Gangrenosum: An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 8.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "A 19-year-old man with nodulocystic acne on baseline was treated with isotretinoin therapy." | 8.84 | Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic. ( Avelleira, JC; Azulay, D; Maciel, G; Soares, D; Tamler, C; Tinoco, MP, 2008) |
| "Pyoderma gangrenosum is a rare autoimmune disorder that can affect the eye." | 5.34 | Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy. ( Baltatzis, S; Foster, CS; Teasley, LA, 2007) |
| "Pyoderma gangrenosum is rare, and treatment is non-surgical." | 5.29 | Bilateral pyoderma gangrenosum of the hand: treatment with dapsone. ( Brown, RE; Graham, D; Lay, L, 1993) |
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 4.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "A 19-year-old man with nodulocystic acne on baseline was treated with isotretinoin therapy." | 4.84 | Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic. ( Avelleira, JC; Azulay, D; Maciel, G; Soares, D; Tamler, C; Tinoco, MP, 2008) |
| " Histological analysis of one of these nodules resulted in diagnosis of chronic erythema elevatum diutinum and treatment with dapsone was initiated." | 3.76 | [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. ( Andre, C; Bagot, M; Duriez, P; Lascaux-Cametz, AS; Maksimovic, L; Ortonne, N; Revuz, J, 2010) |
| "The 'dapsone syndrome' developed in a 44-year-old woman who was treated for pyoderma gangrenosum with 100 mg/day dapsone for about 5 weeks." | 3.69 | A case of the 'dapsone syndrome'. ( Ikezawa, Z; Kim, S; Miyamoto, H; Saito, S, 1994) |
| "Pyoderma gangrenosum is usually diagnosed in the third to sixth decade, but early debut in childhood is also described." | 2.52 | Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature. ( Andersen, AK; Bendstrup, E; Fogh, C; Gade, M; Hilberg, O; Studstrup, F, 2015) |
| "In 1964, Sweet described an acute febrile neutrophilic dermatosis." | 2.43 | From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. ( Vignon-Pennamen, MD; Wallach, D, 2006) |
| "Atypical pyoderma gangrenosum is a rare variant of pyoderma gangrenosum that occurs on the upper extremities, presenting as a cutaneous ulcer." | 1.38 | Atypical pyoderma gangrenosum of the dorsal hand mimicking squamous cell carcinoma. ( Baniahmad, O; Cognetta, AB; Green, WH; Hatfield, HK; Wolfe, CM, 2012) |
| "Neutrophilic dermatoses are inflammatory disorders where normal neutrophils infiltrate the skin without infection." | 1.37 | [Neutrophilic dermatoses]. ( Chosidow, O; Soutou, B; Vignon-Pennamen, D, 2011) |
| "Pyoderma gangrenosum is a rare autoimmune disorder that can affect the eye." | 1.34 | Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy. ( Baltatzis, S; Foster, CS; Teasley, LA, 2007) |
| "Pyoderma gangrenosum is an ulcerative disease of the skin of unknown cause and generally associated to systemic illnesses." | 1.31 | [Pyoderma gangrenosum: report of 11 cases]. ( Amaro, P; Aranibar, L; López de Maturana, D; Segovia, L, 2001) |
| "Pyoderma gangrenosum is rare, and treatment is non-surgical." | 1.29 | Bilateral pyoderma gangrenosum of the hand: treatment with dapsone. ( Brown, RE; Graham, D; Lay, L, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (21.95) | 18.2507 |
| 2000's | 12 (29.27) | 29.6817 |
| 2010's | 20 (48.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Partridge, ACR | 1 |
| Bai, JW | 1 |
| Rosen, CF | 1 |
| Walsh, SR | 1 |
| Gulliver, WP | 1 |
| Fleming, P | 1 |
| Sardana, K | 1 |
| Bajaj, S | 1 |
| Bose, SK | 1 |
| Din, RS | 1 |
| Tsiaras, WG | 1 |
| Li, DG | 1 |
| Mostaghimi, A | 1 |
| Wolfsperger, F | 1 |
| Müller, A | 1 |
| Kofler, L | 1 |
| Yazdi, A | 1 |
| Mizukami, Y | 1 |
| Imanishi, H | 1 |
| Tateishi, C | 1 |
| Kaneshiro, S | 1 |
| Sowa-Osako, J | 1 |
| Ohsawa, M | 1 |
| Tsuruta, D | 1 |
| Staub, J | 1 |
| Pfannschmidt, N | 1 |
| Strohal, R | 1 |
| Braun-Falco, M | 1 |
| Lohse, P | 1 |
| Goerdt, S | 1 |
| Leverkus, M | 1 |
| Gade, M | 1 |
| Studstrup, F | 1 |
| Andersen, AK | 1 |
| Hilberg, O | 1 |
| Fogh, C | 1 |
| Bendstrup, E | 1 |
| Alani, A | 2 |
| Sadlier, M | 1 |
| Ramsay, B | 1 |
| Ahmad, K | 2 |
| Panés-Rodríguez, A | 1 |
| Arregui-Murua, MA | 1 |
| Gutiérrez-Támara, P | 1 |
| Borja-Consigliere, HA | 1 |
| Rodríguez-Pérez, I | 1 |
| Tuneu-Valls, A | 1 |
| Farhi, D | 1 |
| Wallach, D | 2 |
| Tinoco, MP | 1 |
| Tamler, C | 1 |
| Maciel, G | 1 |
| Soares, D | 1 |
| Avelleira, JC | 1 |
| Azulay, D | 1 |
| Ghosh, SK | 1 |
| Bandyopadhyay, D | 1 |
| Chatterjee, G | 1 |
| Ciurea, AM | 1 |
| Guitart, J | 1 |
| Brieva, J | 1 |
| Maksimovic, L | 1 |
| Duriez, P | 1 |
| Lascaux-Cametz, AS | 1 |
| Andre, C | 1 |
| Bagot, M | 1 |
| Revuz, J | 1 |
| Ortonne, N | 1 |
| Paramkusam, G | 1 |
| Meduri, V | 1 |
| Gangeshetty, N | 1 |
| Reddick, CL | 1 |
| Singh, MN | 1 |
| Chalmers, RJ | 1 |
| Soutou, B | 1 |
| Vignon-Pennamen, D | 1 |
| Chosidow, O | 1 |
| Handler, MZ | 1 |
| Hamilton, H | 1 |
| Aires, D | 1 |
| Cunha, VS | 1 |
| Magno, V | 1 |
| Wendt, LR | 1 |
| Furian, TQ | 1 |
| Passos, EP | 1 |
| Wanich, T | 1 |
| Swanson, AN | 1 |
| Wyatt, AJ | 1 |
| Kelly, AM | 1 |
| Wolfe, CM | 1 |
| Green, WH | 1 |
| Cognetta, AB | 1 |
| Baniahmad, O | 1 |
| Hatfield, HK | 1 |
| Goldminz, AM | 1 |
| Botto, NC | 1 |
| Gottlieb, AB | 1 |
| Crawford, CL | 1 |
| Joshi, A | 1 |
| Asahina, A | 1 |
| Minatani, Y | 1 |
| Tada, Y | 1 |
| Mitsui, H | 1 |
| Tamaki, K | 1 |
| Vignon-Pennamen, MD | 1 |
| Teasley, LA | 1 |
| Foster, CS | 1 |
| Baltatzis, S | 1 |
| Cheng, S | 1 |
| Edmonds, E | 1 |
| Ben-Gashir, M | 1 |
| Yu, RC | 1 |
| Maier, H | 1 |
| Diem, E | 1 |
| Gotschim, A | 1 |
| Ortel, B | 1 |
| Wayte, JA | 1 |
| Rogers, S | 1 |
| Powell, FC | 1 |
| Cairns, BA | 1 |
| Herbst, CA | 1 |
| Sartor, BR | 1 |
| Briggaman, RA | 1 |
| Koruda, MJ | 1 |
| Saito, S | 1 |
| Ikezawa, Z | 1 |
| Miyamoto, H | 1 |
| Kim, S | 1 |
| Kar, PM | 1 |
| Aronoff, G | 1 |
| Schuette, P | 1 |
| Brown, RE | 1 |
| Lay, L | 1 |
| Graham, D | 1 |
| Wagner, A | 1 |
| Marosi, C | 1 |
| Binder, M | 1 |
| Röggla, G | 1 |
| Staudinger, T | 1 |
| Keil, F | 1 |
| Locker, GJ | 1 |
| Frass, M | 1 |
| Erdi, H | 1 |
| Anadolu, R | 1 |
| Pişkin, G | 1 |
| Gürgey, E | 1 |
| Fukuhara, K | 1 |
| Urano, Y | 1 |
| Kimura, S | 1 |
| Hori, K | 1 |
| Arase, S | 1 |
| Kaddoura, IL | 1 |
| Amm, C | 1 |
| Hoffman, MD | 1 |
| López de Maturana, D | 1 |
| Amaro, P | 1 |
| Aranibar, L | 1 |
| Segovia, L | 1 |
11 reviews available for dapsone and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials.
Topics: Administration, Oral; Biological Products; Clinical Trials as Topic; Cyclosporine; Dapsone; Dose-Res | 2018 |
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Topics: Acne Vulgaris; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Comb | 2015 |
Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.
Topics: Anti-Infective Agents; Biopsy; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Female; | 2015 |
The neutrophilic dermatoses.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Biopsy; C | 2008 |
Pyoderma gangrenosum following isotretinoin therapy for acne nodulocystic.
Topics: Acne Vulgaris; Dapsone; Follow-Up Studies; Humans; Isotretinoin; Male; Prednisone; Pyoderma Gangreno | 2008 |
Pyoderma gangrenosum with oral involvement - case report and review of the literature.
Topics: Adult; Anti-Infective Agents; Chlorhexidine; Dapsone; Drug Therapy, Combination; Female; Glucocortic | 2010 |
Pyoderma gangrenosum following patellar tendon repair: a case report and review of the literature.
Topics: Anti-Bacterial Agents; Cephalexin; Ciprofloxacin; Dapsone; Drug Therapy, Combination; Glucocorticoid | 2012 |
From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research.
Topics: Abscess; Anti-Inflammatory Agents; Arthritis; Case Management; Dapsone; Digestive System Diseases; F | 2006 |
Subcorneal pustular dermatosis: 50 years on.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blister; Dapsone; Diagnosis, Differential; Female; Humans; | 2008 |
Peristomal pyoderma gangrenosum and inflammatory bowel disease.
Topics: Adolescent; Adult; Biopsy; Colostomy; Crohn Disease; Dapsone; Female; Humans; Ileostomy; Inflammatio | 1994 |
A rationale for adjuvant surgical intervention in pyoderma gangrenosum.
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Dapsone; Debridement; Dexamethasone; Female; Fo | 2001 |
30 other studies available for dapsone and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Arthritis, Infectious; Cost-Benefit Analysis; Dapsone; Derm | 2019 |
Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.
Topics: Administration, Oral; Anti-Infective Agents; Dapsone; Female; Humans; Male; Middle Aged; Pyoderma Ga | 2018 |
[Two neutrophilic dermatoses and one multiple myeloma : A case report].
Topics: Dapsone; Dermatitis; Humans; Multiple Myeloma; Neutrophils; Paraproteinemias; Pyoderma Gangrenosum; | 2019 |
Successful treatment of pyostomatitis vegetans with ulcerative colitis using dapsone without systemic steroids.
Topics: Adult; Anti-Infective Agents; Colitis, Ulcerative; Dapsone; Diagnosis, Differential; Female; Humans; | 2019 |
Pyoderma gangrenosum induced by episiotomy.
Topics: Adult; Anti-Infective Agents; Anti-Ulcer Agents; Clobetasol; Dapsone; Diagnosis, Differential; Episi | 2016 |
Pyoderma gangrenosum of the scalp: pathergic response to herpes zoster infection.
Topics: Aged; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Glucocorticoids; Herpes Zoster; Hum | 2017 |
Vulvar superficial granulomatous pyoderma successfully treated with dapsone.
Topics: Dapsone; Female; Granuloma; Humans; Middle Aged; Pyoderma Gangrenosum; Vulvar Diseases | 2017 |
Pyoderma gangrenosum.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Female; Humans; Prednisolone; Pyode | 2008 |
Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone.
Topics: Anti-Infective Agents; Dapsone; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Ther | 2010 |
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient].
Topics: Dapsone; Dermis; Erythema; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neutrophils; Py | 2010 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Com | 2010 |
[Neutrophilic dermatoses].
Topics: Colchicine; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Glucoc | 2011 |
Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents; Dapsone; Follow-Up Studies; Humans; Ileosto | 2011 |
Pyoderma gangrenosum postlaparoscopy: a rare complication.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Combinations; Female; Glucocorticoids; Humans; Laparosco | 2012 |
Atypical pyoderma gangrenosum of the dorsal hand mimicking squamous cell carcinoma.
Topics: Aged; Amputation, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Carcinoma, Squa | 2012 |
Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Glucocorticoids; Humans; Male; M | 2012 |
The schizophrenic career of a "monster drug".
Topics: Dapsone; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Nervous System | 2003 |
Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Behcet Syndrome; Combined Modality Therapy; Dapso | 2004 |
Successful treatment of Pyoderma gangrenosum with potassium iodide.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Dermatologic Agents; | 2006 |
Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Face; Female; Follow-Up Studies; Hu | 2007 |
[Pyoderma gangrenosum as a precursor of myeloid leukemia].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia | 1995 |
Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Erythema; Humans; Immunoglobulin A; Male; Minocycline; Mo | 1995 |
A case of the 'dapsone syndrome'.
Topics: Adult; Dapsone; Drug Eruptions; Female; Humans; Pyoderma Gangrenosum; Skin | 1994 |
Bronchopulmonary disease: an association with ulcerative colitis and pyoderma gangrenosum.
Topics: Adult; Biopsy; Bronchopneumonia; Colitis, Ulcerative; Dapsone; Drug Therapy, Combination; Female; Hu | 1993 |
Bilateral pyoderma gangrenosum of the hand: treatment with dapsone.
Topics: Aged; Dapsone; Hand Dermatoses; Humans; Male; Potassium Permanganate; Pyoderma Gangrenosum; Silver S | 1993 |
Fatal poisoning due to dapsone in a patient with grossly elevated methaemoglobin levels.
Topics: Anti-Infective Agents; Dapsone; Drug Overdose; Fatal Outcome; Female; Humans; Methemoglobinemia; Mid | 1995 |
Malignant pyoderma: a clinical variant of pyoderma gangrenosum.
Topics: Adrenal Cortex Hormones; Adult; Clofazimine; Dapsone; Female; Folliculitis; Humans; Pyoderma Gangren | 1996 |
Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; Female; Humans; Lung | 1998 |
Pyoderma gangrenosum associated with c-ANCA (h-lamp-2).
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antigens, CD; Biopsy; | 2001 |
[Pyoderma gangrenosum: report of 11 cases].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Dapsone; Female; Follow-Up Studies; Humans; | 2001 |